An exchange-traded fund designed to provide targeted exposure to companies developing or enabling messenger RNA (mRNA) technologies used in vaccines and therapeutics. The portfolio typically includes biotechnology firms involved in mRNA drug development as well as related platform and tooling provid...
No congressional trades have been disclosed for Direxion mRNA ETF (MSGR) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.